Safety of Intravenous Infusion of BPC157 in HumansPubMed 2018 Injectable therapeutic peptides an adjunct to regenerative medicinePubMed BPC-157 is on FDA list of bulk drug substances that present significant safety risks
Decoded: The Peptide BPC-157 and Tendon Injuries What is BPC-157, and Should You Use It for Tendon Injuries
Researched applications The published preclinical literature documents the effects of BPC-157 in the following areas (mostly in animal models): Tendon and ligament healing , Achilles tendon, medial collateral ligament (MCL, the ligament on the inner side of the knee), tendinopathy models Muscle injuries , quadriceps (front thigh), gastrocnemius (calf muscle), transections and contusions Bone and joint healing , osteoarthritis models, fracture healing, periodontal tissues (around the teeth) Gastrointestinal diseases , gastric lesions caused by alcohol or NSAIDs (ibuprofen, diclofenac), colitis, IBD models (Crohns disease), fistulas Hepatoprotection , protection of the liver against toxic damage (paracetamol overdose, CCl, alcohol) Vascular healing , endothelial dysfunction, thromboses, healing of vascular anastomoses after surgery, thrombocytopenia (low platelet count) Skin wounds , acute as well as diabetic wounds, burns Nerve regeneration , peripheral (sciatic nerve crush) as well as central (cerebral ischemia models, i.e
Dawson-Hughes, B., Staten, M
Weight loss: beyond the GLP-1 conversation GLP-1 drugs like Ozempic deliver results but at a cost rarely mentioned: they cause significant muscle and tissue loss alongside fat
